Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GenoSafe logo — Your bioanalytical CRO partner for Gene and Cell Therapies

GenoSafe

Your bioanalytical CRO partner for Gene and Cell Therapies

Founded 2003 France France 42 employees Biotechnology

General Information

Company Name GenoSafe
Founded Year 2003
Location France France +1
Employees 42
Industries Biotechnology
Social

Get notified when GenoSafe moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GenoSafe

GenoSafe is a biotechnology startup that positions itself as a bioanalytical CRO partner for gene and cell therapies. With the slogan "Your bioanalytical CRO partner for Gene and Cell Therapies," GenoSafe offers analytical testing services for the evaluation of the quality, safety, and efficacy of gene and cell therapy candidates. This includes GLP biodistribution, shedding, and immunogenicity studies, as well as QC testing such as viral titration, safety, and potency/efficacy testing, and GCP bioanalysis of patient samples, encompassing immunogenicity, shedding, and gene expression studies. Founded in 2003, GenoSafe boasts over 15 years of experience in the development, qualification, and validation of key analytical methods for product and sample testing. The startup has carved its niche in the biotechnology industry by specializing in services critical to the advancement of gene and cell therapies. Despite the absence of specific information on headquarters, last investment, or last investment investors, GenoSafe's stronghold in the biotechnology sector and its specific focus on crucial analytical testing services for gene and cell therapy candidates make it a potential point of interest for venture capital firms seeking opportunities in the biotechnology space. With its established expertise and strong positioning, GenoSafe presents itself as a potential prospect for investment within the biotech sector.

Taxonomy: Analytical Testing, Gene and Cell Therapies, GLP Studies, QC Testing, Bioanalysis, Immunogenicity Studies, Viral Titration, Potency Testing, Sample Testing, Validation Methods, Molecular Biology, Immunology, Gene Therapy, Cell Therapy

No funding data available for GenoSafe yet.

Get notified when GenoSafe raises funding

GenoSafe Alternatives & Competitors

GenoSafe vs
Levostar Biotech
Levostar Biotech United States

We provide leading edge services and products supporting the development of cell and gene therapies,...

Seed
4 employees
Biotechnology, Health Care
GenoSafe vs
Texcell
Texcell France

Expert in viral safety since 1987.

112 employees
Life Sciences, Pharmaceutical
GenoSafe vs
Proton Bio
Proton Bio

Empowering breakthroughs in Cell and Gene Therapy with comprehensive development and manufacturing s...

Series B
201-500 employees
Biopharma, Biotechnology

FAQ About GenoSafe

Your bioanalytical CRO partner for Gene and Cell Therapies
GenoSafe was founded in 2003.
GenoSafe is headquartered in France.
GenoSafe operates in the following industries: Biotechnology.
GenoSafe has approximately 42 employees.
Top alternatives and competitors to GenoSafe include Levostar Biotech, Texcell, Proton Bio, WuXi Advanced Therapies, Noble Life Sciences Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenoSafe and Levostar Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GenoSafe and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes